Sign In
Buy AIMLF
$0.0312
-0.0047 (-13.09%)
At Close: Jul 31, 2026
Agreement positions NeuralCloud's AI-driven cardiac platform for Holter monitoring and ambulatory patient workflow. Partnership introduces CardioYield™ powered by MaxYield™ for automated, reliable
AI/ML Appoints Erik Suokas as Chief Operating Officer to Accelerate Commercial Execution and Operational Scale
07:00am, Wednesday, 07'th Jan 2026
Appointment Supports AIML's Commercial Execution and Operational Scale as the Company Advances Its AI-Driven Cardiac Platform Leadership Addition Aligns Revenue, Delivery, and Product Execution as AIM
AIML Announces the Conclusion of Consulting Agreement and Leadership Transition for President & Chief Commercial Officer
07:30am, Tuesday, 30'th Dec 2025
TORONTO, ON / ACCESS Newswire / December 30, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) has announced that its consulting agreement with Campfire Propert
Join AIML's Live Shareholder Update with Chairman & CEO Paul Duffy
07:30am, Tuesday, 16'th Dec 2025
A Look Back at Key Milestones and Successes Achieved in 2025 What's Ahead: Exciting Plans, Strategic Outlook, and Goals for 2026 Advancing the Next Phase of Commercialization TORONTO, ON / ACCESS News
This strengthens NeuralCloud's expansion into the global wellness and B2B health practitioner delivery model with high-fidelity cardiac signal processing and digital health integration. Partnership po
Early collaboration supports development of Cornerstone's emerging athlete-performance program and extends NeuralCloud's ECG analytics into sports-science and human performance markets Pilot ties MaxY
Agreement expands NeuralCloud's AI-enhanced ECG signal-processing technology into veterinary health and elite equine performance markets Commercial integration expands MaxYield™ and CardioYield™ i
AI/ML Subsidiary Neural Cloud Begins Pilot at SickKids to Advance AI-Enabled Pediatric Cardiac Care
07:30am, Monday, 24'th Nov 2025
Pilot Project to Explore AI-Driven ECG Signal Processing and Predictive Deterioration Models in Pediatric Cardiac Care TORONTO, ON / ACCESS Newswire / November 24, 2025 / NeuralCloud Solutions Inc. ("
AI/ML Innovations Inc. Announces Grant of U.S. Patent Protecting Core ECG Signal-Processing Architecture
07:30am, Tuesday, 11'th Nov 2025
Patent validates AIML's novel neural-network approach to denoising and mapping ECG signals, powering MaxYield™ and CardioYield™. Reinforces competitive advantage as the Company advances commercial
AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants to Lead Regulatory Submission for CardioYield(TM) in Jamaica
07:30am, Tuesday, 04'th Nov 2025
Collaboration Advances Local Regulatory Pathway for AI-Enabled ECG Diagnostics to Address the Growing Cardiovascular Disease Burden in Jamaica TORONTO, ON / ACCESS Newswire / November 4, 2025 / AI/ML
AIML Subsidiary NeuralCloud Solutions Commencing Pilot with Canadian Cardiology Clinic to Advance AI-Powered ECG Reporting
07:30am, Tuesday, 21'st Oct 2025
NeuralCloud Solutions to deploy its CardioYield™ platform in a multi-stage pilot program with a full-service cardiology clinic in Canada. Enhance Holter ECG analysis accuracy, efficiency, and workfl
AIML Subsidiary NeuralCloud Solutions and Heartdent Center Ltd. Launch Pilot Project to Advance Cardiac Care in Jamaica
07:30am, Wednesday, 15'th Oct 2025
Pilot Study to Lay the Groundwork for Expansion Across Jamaica Goal of the Collaboration is to Demonstrate the Ability to Deliver Affordable, Accurate, and Scalable Holter Diagnostics with CardioYield
AIML Subsidiary NeuralCloud Solutions and Toronto Heart Centre Launch a Pilot Program to Test AI-Powered Holter ECG Reporting
07:00am, Tuesday, 07'th Oct 2025
Pilot Evaluation: Toronto Heart Centre to conduct comparative testing of CardioYield™ for enhanced Holter ECG analysis and reporting efficiency. Clinical Workflow Impact: Study to measure time savin
AIML and BC Brain Wellness Program Launch Pilot to Explore the Heart–Brain Connection
07:00am, Tuesday, 30'th Sep 2025
Leveraging MaxYield™ ECG to capture real-world exercise data in people living with neurological conditions Generating actionable insights into how cardiac responses may correlate with brain health a
AIML Announces Closing of Oversubscribed Private Placement
08:15pm, Monday, 22'nd Sep 2025
VANCOUVER, BC / ACCESS Newswire / September 22, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that Company completed its previously a
